| Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single … TW Laetsch, GD Myers, A Baruchel, AC Dietz, MA Pulsipher, H Bittencourt, ... The Lancet Oncology 20 (12), 1710-1718, 2019 | 91 | 2019 |
| Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro A McDowall, L Svensson, P Stanley, I Patzak, P Chakravarty, K Howarth, ... Blood, The Journal of the American Society of Hematology 115 (23), 4834-4842, 2010 | 78 | 2010 |
| Targeting MYC dependence by metabolic inhibitors in cancer HS Sabnis, RR Somasagara, KD Bunting Genes 8 (4), 114, 2017 | 38 | 2017 |
| Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine HS Sabnis, HL Bradley, S Tripathi, WM Yu, W Tse, CK Qu, KD Bunting Leukemia research 50, 132-140, 2016 | 31 | 2016 |
| Leukocyte adhesion deficiency‐III in an African‐American patient H Sabnis, A Kirpalani, J Horan, A McDowall, L Svensson, A Cooley, ... Pediatric Blood & Cancer 55 (1), 180-182, 2010 | 26 | 2010 |
| Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia H Sabnis, HL Bradley, ST Bunting, TM Cooper, KD Bunting Journal of translational medicine 12, 1-13, 2014 | 23 | 2014 |
| Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma RS Nickel, F Keller, J Bergsagel, T Cooper, M Daves, H Sabnis, G Lew Pediatric blood & cancer 61 (5), 810-814, 2014 | 23 | 2014 |
| Severe COVID‐19 disease in two pediatric oncology patients CL Stokes, PA Patel, HS Sabnis, SG Mitchell, IB Yildirim, MG Pauly Pediatric Blood & Cancer 67 (9), 2020 | 20 | 2020 |
| Molecular targets for the treatment of juvenile myelomonocytic leukemia X Liu, H Sabnis, KD Bunting, CK Qu Advances in Hematology 2012 (1), 308252, 2012 | 17 | 2012 |
| Growth disturbances in children and adolescents receiving long‐term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome‐positive Acute … HS Sabnis, C Keenum, RW Lewis, B Patterson, J Bergsagel, KE Effinger, ... British Journal of Haematology 185 (4), 2019 | 15 | 2019 |
| Single-cell analysis reveals altered tumor microenvironments of relapse-and remission-associated pediatric acute myeloid leukemia H Mumme, BE Thomas, SS Bhasin, U Krishnan, B Dwivedi, P Perumalla, ... Nature Communications 14 (1), 6209, 2023 | 14 | 2023 |
| Pimozide and imipramine blue exploit mitochondrial vulnerabilities and reactive oxygen species to cooperatively target high risk acute myeloid leukemia Z Wang, T Mi, HL Bradley, J Metts, H Sabnis, W Zhu, J Arbiser, ... Antioxidants 10 (6), 956, 2021 | 6 | 2021 |
| Immune responses and therapeutic challenges in paediatric patients with new‐onset acute myeloid leukaemia and concomitant COVID‐19 PA Patel, SA Lapp, G Grubbs, VV Edara, CA Rostad, CL Stokes, ... British Journal of Haematology 194 (3), 549-553, 2021 | 5 | 2021 |
| Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias SM Smith, HS Sabnis, RW Lewis, KE Effinger, J Bergsagel, B Patterson, ... BMC cancer 21 (1), 474, 2021 | 5 | 2021 |
| Factors affecting same-day cancelation of outpatient pediatric oncologic procedural sedation JR Grunwell, LD Long, LN Bryan, T Kelley, HS Sabnis, HK Simon, ... Pediatric hematology and oncology 35 (5-6), 309-315, 2018 | 5 | 2018 |
| Early T‐Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia SS Raikar, JD Scarborough, H Sabnis, J Bergsagel, D Wu, TM Cooper, ... Pediatric Blood & Cancer 63 (9), 1667-1670, 2016 | 5 | 2016 |
| Multicenter analysis of genomically targeted single patient use requests for pediatric neoplasms HS Sabnis, DS Shulman, B Mizukawa, N Bouvier, A Zehir, J Fangusaro, ... Journal of Clinical Oncology 39 (34), 3822-3828, 2021 | 4 | 2021 |
| A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes HS Sabnis, KA Minson, C Monroe, K Allen, JL Metts, TM Cooper, ... Leukemia Research 96, 106421, 2020 | 4 | 2020 |
| Acute myeloid leukemia in an infant with t (8; 19)(p11. 2; q13) translocation: case report and a review of the literature AC Eason, ST Bunting, JF Peterson, D Saxe, HS Sabnis Case reports in hematology 2019 (1), 4198415, 2019 | 4 | 2019 |
| Absence of silent inactivation using intravenous pegaspargase in pediatric acute lymphoblastic leukemia S Kumar, CD Travers, J Bergsagel, FG Keller, M Pauly, H Sabnis, ... Blood 130, 100, 2017 | 4 | 2017 |
